Virginie Pautret

Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099

Thomas J. Lynch, Taral Patel, Luke Dreisbach et al. · Journal of Clinical Oncology · 2010 · 448 citations

Medicine, Oncology, Pharmacology +17

Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer

Charles Butts, David Bodkin, Edward L. Middleman et al. · Journal of Clinical Oncology · 2007 · 196 citations · Full text

Medicine, Oncology, Pharmacology +17

Vinflunine in platinum‐pretreated patients with locally advanced or metastatic urothelial carcinoma

David J. Vaughn, Sandy Srinivas, Walter M. Stadler et al. · Cancer · 2009 · 115 citations · Full text

Medicine, Oncology, Pharmacology +14

B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

Thomas J. Lynch, Taral Patel, Luke Dreisbach et al. · Journal of Thoracic Oncology · 2007 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Cetuximab plus irinotecan for metastatic colorectal cancer (mCRC): Safety analysis of 800 patients in a randomized phase III trial (EPIC)

Y. Abubakr, Cathy Eng, Lucas Wong et al. · Journal of Clinical Oncology · 2006 · 24 citations

Medicine, Oncology, Pharmacology +16